InsiderClue
Stocks · Health care · Pharmaceutical Preparations

PRF Technologies Ltd.

PRFX Clue Score38
Israel Fiscal year ends December CIK 0001801834
$0.82 -4.88% Close, 13 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.82 −68.90% Close, 13 Oct 2026

Closing prices at the end of each trading day, from 1 Sep 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2018Operating income−0.5Net income−0.8Fiscal year 2019Operating income−0.7Net income−1.3Fiscal year 2020Operating income−1.7Net income−4.1EPS, diluted−1.25Fiscal year 2021Operating income−7.2Net income−7.2EPS, diluted−7.25Fiscal year 2022Operating income−8.9Net income−8.8EPS, diluted−63.46Fiscal year 2023Revenue0.0Operating income−9.6Net income−9.3EPS, diluted−122.94Fiscal year 2024Revenue0.0Operating income−14.7Net income−14.6EPS, diluted−105.52Fiscal year 2025Revenue0.0Operating income−5.1Net income−5.0EPS, diluted−7.47
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a n/a n/a n/a 0.0 0.0 0.0
Growth
Operating income −0.5 −0.7 −1.7 −7.2 −8.9 −9.6 −14.7 −5.1
Net income −0.8 −1.3 −4.1 −7.2 −8.8 −9.3 −14.6 −5.0
Growth
EPS, diluted n/a n/a −1.25 −7.25 −63.46 −122.94 −105.52 −7.47

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2018Fiscal year 2019Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Fiscal year 2025Operating margin−30,129.4%Net margin−29,541.2%Free cash flow margin−23,276.5%
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a n/a n/a n/a n/a n/a −30,129.4%
Net margin n/a n/a n/a n/a n/a n/a n/a −29,541.2%
Free cash flow margin n/a n/a n/a n/a n/a n/a n/a −23,276.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2018Operating cash flow−0.6Fiscal year 2019Operating cash flow−0.6Capital expenditure0.0Free cash flow−0.6Fiscal year 2020Operating cash flow−2.6Capital expenditure−0.0Free cash flow−2.6Fiscal year 2021Operating cash flow−6.6Capital expenditure−0.1Free cash flow−6.6Fiscal year 2022Operating cash flow−6.5Capital expenditure−0.0Free cash flow−6.5Fiscal year 2023Operating cash flow−6.7Capital expenditure−0.0Free cash flow−6.7Fiscal year 2024Operating cash flow−12.6Capital expenditure−0.0Free cash flow−12.6Fiscal year 2025Operating cash flow−4.0Capital expenditure−0.0Free cash flow−4.0
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −0.6 −0.6 −2.6 −6.6 −6.5 −6.7 −12.6 −4.0
Capital expenditure n/a 0.0 −0.0 −0.1 −0.0 −0.0 −0.0 −0.0
Free cash flow n/a −0.6 −2.6 −6.6 −6.5 −6.7 −12.6 −4.0
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash and securities
Fiscal year 2018Cash and securities0.0Shareholders’ equity−11.1Fiscal year 2019Cash and securities0.9Shareholders’ equity−12.2Fiscal year 2020Cash and securities15.7Shareholders’ equity16.6Fiscal year 2021Cash and securities16.5Shareholders’ equity18.1Fiscal year 2022Cash and securities10.2Shareholders’ equity11.0Fiscal year 2023Cash and securities8.0Shareholders’ equity7.2Fiscal year 2024Cash and securities4.3Shareholders’ equity1.8Fiscal year 2025Cash and securities3.1Shareholders’ equity8.5
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and securities 0.0 0.9 15.7 16.5 10.2 8.0 4.3 3.1
Shareholders’ equity −11.1 −12.2 16.6 18.1 11.0 7.2 1.8 8.5

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024 31 Dec 2024 FY2025† 31 Dec 2025
Assets
0.0 0.9 15.7 16.5 4.1 8.0 4.3 3.1
n/a n/a n/a 0.0 6.1 0.0 n/a n/a
n/a n/a 0.0 0.1 0.0 0.0 0.0 0.0
n/a n/a n/a n/a n/a n/a 0.0 0.2
n/a 1.2 17.8 19.1 12.3 9.9 4.5 12.0
Growth +1,429.3% +7.1% −35.4% −19.5% −54.4% +165.1%
Liabilities
n/a n/a 1.2 1.0 1.3 2.7 2.7 2.7
Equity
n/a −12.4 −16.5 −23.7 −32.5 −41.9 −56.5 −61.3
−11.1 −12.2 16.6 18.1 11.0 7.2 1.8 8.5
Growth +8.8% −39.0% −34.3% −74.8% +368.4%
Per share and net cash
n/a 0.6 8.8 10.5 10.6 1.7 1.5 0.8
calc n/a −21.23 1.90 1.73 1.04 4.19 1.24 10.29

† The number of shares outstanding jumps at 2020 and 2023 and 2025, so per-share figures either side of that column are not comparable. Usually a split. This count is a different filed figure from the diluted average on the income statement, so it can break in a different year.

Lines marked calc are worked out here from filed figures; point at one for how.